Topera, Inc., has announced (pdf) it has completed a $25 million Series C financing round.

Topera Medical (Topera, Inc.) is a venture-backed medical device company, based in San Diego, Calif. It is the developer of a 3D analysis and mapping system designed to assist electrophysiologists in the identification of the electrical source of complex cardiac arrhythmias.

The financing round was led by new investor New Enterprise Associates (NEA).

NEA is a venture capital firm headquartered in Menlo Park, Calif., that invests across stage and geography in technology, healthcare and energy.

Proceeds from the financing will be used in part to support the planned 2013 commercial launch of Topera’s RhythmView workstation and FIRMap catheter in Europe and the U.S.